Filtered By:
Specialty: International Medicine & Public Health
Drug: Aspirin
This page shows you your search results in order of date. This is page number 2.
Order by Relevance | Date
Total 37 results found since Jan 2013.
Opportunities for intervention: stroke treatments, disability and mortality in urban Tanzania
ConclusionsThe 90-day mortality of stroke presenting at MNH is 50%, much higher than in higher income settings. Although severe stroke presentations are a major factor, efforts to improve the quality of care and prevent complications of stroke are urgently needed. Acute stroke interventions with low number needed to treat represent challenging long-term goals.
Source: International Journal for Quality in Health Care - August 28, 2018 Category: International Medicine & Public Health Source Type: research
International study suggests combination therapy may prevent stroke in certain people
(NIH/National Institute of Neurological Disorders and Stroke) Results from an international clinical trial of more than 4880 participants, published in the New England Journal of Medicine, show that combining clopidogrel and aspirin following a small stroke or experiencing minor stroke symptoms decreases risk of a new stroke, heart attack or other ischemic event within 90 days. The combination therapy was also associated with an increase in major bleeding, although many of those episodes were non-fatal and did not occur in the brain.
Source: EurekAlert! - Medicine and Health - May 17, 2018 Category: International Medicine & Public Health Source Type: news
Stroke prevention drug combo shows promise, study says
(University of Texas at Austin) If you've had a minor stroke or a transient ischemic stroke (TIA), taking the clot-preventing drug clopidogrel along with aspirin may lower your risk of having a major stroke within the next 90 days, according to new research published in The New England Journal of Medicine.
Source: EurekAlert! - Medicine and Health - May 16, 2018 Category: International Medicine & Public Health Source Type: news
Aspirin lowers risk of death for patients with diabetes, heart failure
(American College of Cardiology) For people living with both Type 2 diabetes and heart failure, taking an aspirin each day appears to lower the risk of dying or being hospitalized for heart failure, according to research being presented at the American College of Cardiology's 67th Annual Scientific Session. But the data also reveal aspirin use may increase the risk of nonfatal heart attack or stroke, a somewhat contradictory finding that surprised researchers.
Source: EurekAlert! - Medicine and Health - February 28, 2018 Category: International Medicine & Public Health Source Type: news
HIV-positive adults receive inferior cardiovascular care compared with those without HIV
(University of California - Los Angeles Health Sciences) People with both HIV and risk factors for heart disease and stroke were less likely to be treated with cholesterol-lowering statin drugs and aspirin than patients without HIV.
Source: EurekAlert! - Social and Behavioral Science - November 21, 2017 Category: International Medicine & Public Health Source Type: news
Risk factors of hemorrhagic and ischemic stroke among hospitalized patients in Bangladesh - A case control study
The risk factor profiles, management and outcome have significant difference between stroke subsets. Aim of this study was to investigate the risk for the two most common subtypes of stroke in Bangladeshi population. Seventy cases of hemorrhagic stroke (HS) and 105 cases of confirmed ischemic stroke (IS) were recruited from the Shaheed Suhrawardy Medical College Hospital (ShSMCH) and Dhaka Medical College Hospital between January-June 2011. Total 171 age, sex matched controls were selected from the hospitalized patients with history of no stroke ever. Average hemorrhagic stroke patients (60.4 ±12.3 years) were younger tha...
Source: Bangladesh Medical Research Council Bulletin - November 3, 2016 Category: Global & Universal Source Type: research
PS084 Stroke Due Discontinuance Irregular of Aspirin in Cirurgies Noncardiacs
Acetylsalicylic acid (ASA) is related to higher rate of postoperative bleeding, however, its discontinuity implies increasing cardiovascular disease and increased perioperative mortality.
Source: CVD Prevention and Control - May 31, 2016 Category: Global & Universal Authors: J.A.D. Silveira, F.J. Matheus, A. Meneghini, A.L. Queiroz, C.J. Arroyo Neto, A.C.P. Chagas Tags: Poster Abstract Source Type: research
Aspirin Versus Clopidogrel in Prevention of Ischemic Stroke Recurrence: An Evaluation of Effectiveness and Safety from Beijing Medical Insurance Database
To evaluate the effectiveness and safety of aspirin and clopidrogel in prevention of ischemic stroke (IS) recurrence from data of Beijing medical insurance database.
Source: Value in Health - April 30, 2016 Category: Global & Universal Authors: L Yang, L Wen, J Wu Source Type: research
Use of aspirin and statins for the primary prevention of myocardial infarction and stroke in patients with human immunodeficiency virus infection
This retrospective, cross-sectional study evaluated whether HIV-infected patients received aspirin and statins for the primary prevention of myocardial infarction and stroke. Among the 258 patients included, 50.4% (n = 130/258) of the patients had a high risk of myocardial infarction and 14% (n = 36/258) of stroke. Overall, 43.1% (n = 56/130) and 50% (n = 18/36) of the patients were prescribed aspirin for the primary prevention of myocardial infarction and stroke, respectively. Among the patients who required statin therapy, 42.5% (n = 34/80) and 37.1% (n = 13/35) of patients received it for the primary prevention of myoca...
Source: International Journal of STD and AIDS - April 6, 2016 Category: Global & Universal Authors: Park, T. E., Yusuff, J., Sharma, R. Tags: Original research articles Source Type: research
Cost-Effectiveness of A Left Atrial Appendage Closure Device In Patients With Non-Valvular Atrial Fibrillation Unable or Unwilling to Tolerate Oral Anticoagulant Therapy In Italy And Spain
Approximately 18-20% of non-valvular atrial fibrillation (NVAF) patients are unable or unwilling to tolerate oral anticoagulant therapy (OAT), leaving them at risk of stroke. Left atrial appendage closure (LAAC) device offers an alternative stroke risk reduction strategy that enables the majority of patients to discontinue long-term systematic OAT. Acknowledging both potential improvements in health outcomes and additional upfront implantation costs of a LAAC device, this study considers the lifetime costs and benefits of LAAC compared to aspirin plus clopidogrel (A+C) in high-risk NVAF patients ineligible or unwilling to ...
Source: Value in Health - October 23, 2015 Category: Global & Universal Authors: A Amin, I Cruz González, V Reddy, D Holmes, S Berti, A Iñiguez Romo, L De Deppo, V Priest, M Simmonds, C Lee, M Wasserman, A Margonato Source Type: research
Aspirin Versus Clopidogrel in Patients with Ischemic Stroke: a Cost and Effectiveness Comparison from Beijing Medical Insurance Database
To compare the cost and effectiveness of aspirin and clopidogrel in ischemic stroke(IS) patients from data of Beijing medical insurance database.
Source: Value in Health - October 23, 2015 Category: Global & Universal Authors: L Wen, J Wu, L Yang Source Type: research
Co-Administration of Proton Pump Inhibitors in Chronic Aspirin Users and the Risk of Adverse Cardiovascular Events: a Population-Based Cohort Study
This study investigated the effect of co-administration of PPIs in aspirin users with a first acute myocardial infarction (AMI) or stroke on the risk of recurrence of such a CV event.
Source: Value in Health - October 23, 2015 Category: Global & Universal Authors: A Tran-Duy, FH Vanmolkot, PC Souverein, AW Hoes, A de Boer, CD Stehower, NJ de Wit, MA Joore, F de Vries Source Type: research
A Cost-Effectiveness Analysis Of Aspirin In The Primary Prevention Of Cardiovascular Diseases And Colorectal Cancer
This study aims to assess the cost-effectiveness of aspirin in the primary prevention of cardiovascular events (myocardial infarction (MI) and ischemic stroke (IS)) and colorectal cancer (CRC) in the low-risk general population in the United States (US).
Source: Value in Health - October 23, 2015 Category: Global & Universal Authors: S Soon, WJ Chia, K Redekop, HL Wee Source Type: research
Clopidogrel Versus Aspirin In Patients With Atherothrombosis: A Caprie-Based Economic Analysis In A Health Resource Limited Setting
To explore the cost-effectiveness of clopidogrel as secondary prevention in patients with a recent ischemic stroke (IS), or established peripheral arterial disease (PAD) compared with aspirin in China.
Source: Value in Health - May 1, 2015 Category: Global & Universal Authors: T. Li, M.B. Liu, H. Ben, Z.X. Xu, H. Zhong, B. Wu Source Type: research
Pharmacoeconomic Assessment Of Apixaban Versus Standard Of Care For The Prevention Of Stroke In Italian Non-Valvular Atrial Fibrillation Patients
The objective of this study was to evaluate the cost-effectiveness of apixaban in the prevention of thromboembolic events in patients with non-valvular atrial fibrillation (NVAF) relatively to standard of care (warfarin or aspirin) from the Italian National Health System (SSN) perspective.
Source: Value in Health - November 1, 2014 Category: Global & Universal Authors: L. Pradelli, M. Calandriello, Virgilio R. Di, M. Bellone, M Tubaro Source Type: research
